Tritace 2.5mg tablets

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)

Veiklioji medžiaga:

Ramipril

Prieinama:

Waymade Healthcare Plc

ATC kodas:

C09AA05

INN (Tarptautinis Pavadinimas):

Ramipril

Dozė:

2.5mg

Vaisto forma:

Oral tablet

Vartojimo būdas:

Oral

Klasė:

No Controlled Drug Status

Recepto tipas:

Valid as a prescribable product

Produkto santrauka:

BNF: 02050501

Pakuotės lapelis

89034670 - 756534. 4/4
89034670 - 756534 1/4
_PACK. ITEM:_
ARKHÉ S.N.C.
Tel. [phone]
fax [phone]
1 - Prima realizzazione
 REFLEX BLUE
SANOFI S.P.A.
Verificare la corrispondenza dell’artwork
approvato - la nostra responsabilità è
limitata al rifacimento dei file forniti.
26-06-2019
IST TRITACE GB I02
ISTRUZIONI
GB: GREAT BRITAIN
89034670
89031942
62C0007 V.1.0
01100001100
167 X 315MM DP
2
-
-
9,5 PT SU 10 PT
756534
2 - Correzione testatina
3 - Modifica testo reg.
4, 1 / 4
PACKAGE LEAFLET:
INFORMATION FOR THE USER
TRITACE
® 1.25MG - 2.5MG
5MG - 10MG TABLETS
TRITACE
® TABLETS TITRATION PACK
Ramipril
IS THIS LEAFLET HARD TO SEE
OR READ?
PHONE [phone]
FOR HELP
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor
or pharmacist.
• This medicine has been prescribed for you only. Do
not pass it on to others. It may harm them even if
their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What TRITACE is and what it is used for
2. What you need to know before you take TRITACE
3. How to take TRITACE
4. Possible side effects
5. How to store TRITACE
6. Contents of the pack and other information
1. WHAT TRITACE IS AND WHAT
IT IS USED FOR
TRITACE contains a medicine called ramipril. This
belongs to a group of medicines called ACE inhibitors
(Angiotensin Converting Enzyme Inhibitors).
TRITACE works by:
• Decreasing your body’s production of substances
that could raise your blood pressure
• Making your blood vessels relax and widen
• Making it easier for your heart to pump blood
around your body.
TRITACE can be used:
• To treat high blood pressure (hypertension)
• To reduce the risk of you having a heart attack or
stroke
• To reduce the risk or del

Prekės savybės

Reference: 4898 1.3.1.01 - SPC 1 - 2.5mg - 2007-04-19 - CCDS V7.1 1.0
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Tritace 2.5 mg Tablets
or
Ramipril 2.5mg Tablet
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Tablets
Each tablet contains ramipril 2.5 mg.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablets 2.5mg
Yellowish to yellow oblong tablet with dimensions of 8 x 4 mm with
score-
line.
Upper stamp: 2.5 & logo (
)
Lower stamp: HMR & 2.5
The tablet can be divided into equal doses.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
- Treatment of hypertension.
- Cardiovascular prevention: reduction of cardiovascular morbidity and
mortality in patients
with:
•
manifest atherothrombotic cardiovascular disease (history of coronary
heart
disease or stroke, or peripheral vascular disease) or
•
diabetes with at least one cardiovascular risk factor (see section
5.1).
- Treatment of renal disease:
•
Incipient glomerular diabetic nephropathy as defined by the presence
of
microalbuminuria,
•
Manifest glomerular diabetic nephropathy as defined by
macroproteinuria in
patients with at least one cardiovascular risk factor (see section
5.1),
Reference: 4898 1.3.1.01 - SPC 1 - 2.5mg - 2007-04-19 - CCDS V7.1 1.0
•
Manifest glomerular non diabetic nephropathy as defined by
macroproteinuria
≥
3 g/day (see section 5.1).
- Treatment of symptomatic heart failure.
- Secondary prevention after acute myocardial infarction: reduction of
mortality from the
acute phase of myocardial infarction in patients with clinical signs
of heart failure when
started > 48 hours following acute myocardial infarction.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
It is recommended that TRITACE is taken each day at the same time of
the day.
TRITACE can be taken before, with or after meals, because food intake
does not modify its
bioavailability (see section 5.2).
TRITACE has to be swallowed with liquid. It must not be chewed or
crushed.
_Adults _
_ _
Diuretic-Treated patients
Hypotension may